Bicycle Therapeutics (BCYC) Insider Trading & Ownership $23.60 +1.40 (+6.31%) (As of 10/4/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Bicycle Therapeutics (NASDAQ:BCYC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$526,764.52 Get BCYC Insider Trade Alerts Want to know when executives and insiders are buying or selling Bicycle Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BCYC Insider Buying and Selling by Quarter Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Bicycle Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/3/2024Kevin LeeCEOSell3,212$22.26$71,499.12 10/3/2024Michael Charles Ferguso HannayInsiderSell247$22.26$5,498.22 10/3/2024Michael SkynnerCTOSell972$22.26$21,636.72 10/3/2024Travis Alvin ThompsonCAOSell153$22.26$3,405.78 7/3/2024Kevin LeeCEOSell3,194$19.64$62,730.16 7/3/2024Michael Charles Ferguso HannayInsiderSell246$19.64$4,831.44 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 7/3/2024Michael SkynnerCTOSell967$19.64$18,991.88 7/3/2024Travis Alvin ThompsonCAOSell148$19.64$2,906.72 4/11/2024Michael Charles Ferguso HannayInsiderSell257$22.49$5,779.93 4/3/2024Kevin LeeCEOSell3,158$23.81$75,191.98 4/3/2024Michael SkynnerCTOSell955$23.81$22,738.55 4/3/2024Nicholas KeenInsiderSell790$23.81$18,809.90 4/3/2024Travis Alvin ThompsonCAOSell152$23.81$3,619.12 1/3/2024Kevin LeeCEOSell8,703$17.50$152,302.50 1/3/2024Nigel CrockettInsiderSell2,643$17.50$46,252.50 1/3/2024Travis Alvin ThompsonCAOSell604$17.50$10,570.00 (Data available from 1/1/2013 forward) BCYC Insider Trading Activity - Frequently Asked Questions Who is on Bicycle Therapeutics's Insider Roster? The list of insiders at Bicycle Therapeutics includes Alistair Milnes, Kevin Lee, Lee Kalowski, Michael Charles Ferguso Hannay, Michael Skynner, Nicholas Keen, Nigel Crockett, Pierre Legault, and Travis Alvin Thompson. Learn more on insiders at BCYC. What percentage of Bicycle Therapeutics stock is owned by insiders? 8.50% of Bicycle Therapeutics stock is owned by insiders. Learn more on BCYC's insider holdings. Which Bicycle Therapeutics insiders have been selling company stock? The following insiders have sold BCYC shares in the last 24 months: Alistair Milnes ($8,840.00), Kevin Lee ($634,453.02), Lee Kalowski ($60,681.26), Michael Charles Ferguso Hannay ($16,109.59), Michael Skynner ($84,123.42), Nicholas Keen ($39,417.59), Nigel Crockett ($98,589.56), and Travis Alvin Thompson ($23,112.72). How much insider selling is happening at Bicycle Therapeutics? Insiders have sold a total of 43,229 Bicycle Therapeutics shares in the last 24 months for a total of $965,327.16 sold. More Insider Trading Tools from MarketBeat Related Companies: Immunic Insider Buying Pieris Pharmaceuticals Insider Buying TG Therapeutics Insider Buying Apellis Pharmaceuticals Insider Buying Apogee Therapeutics Insider Buying MoonLake Immunotherapeutics Insider Buying Rhythm Pharmaceuticals Insider Buying Kymera Therapeutics Insider Buying Bausch Health Companies Insider Buying Dyne Therapeutics Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Insiders Are Betting Big on These 2 StocksThis Is the Top Large-Cap Stock Insiders Are BuyingMatador Resources Insiders Keep Buying Its Stock, Should You?Top 3 Small-Cap Stocks Insiders Are Buying Right Now3 Small Cap Stocks That Insiders Are Buying This page (NASDAQ:BCYC) was last updated on 10/6/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredAI Expert Reveals New PickEveryone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bicycle Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Bicycle Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
